Publications by authors named "Elisabeth Gaye"

Claim this Profile
O
Oxaliplatin-Based Versus Alkylating Agent in Neuroendocrine Tumors According to the O-Methylguanine-DNA Methyltransferase Status: A Randomized Phase II Study (MGMT-NET).
Thomas Walter, Thierry Lecomte, Julien Hadoux, Patricia Niccoli, Léa Saban-Roche, Elisabeth Gaye

J Clin Oncol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel treatment approaches for HER2 positive solid tumors (excluding breast cancer).
Elisabeth Gaye, Nicolas Penel, Loïc Lebellec

Curr Opin Oncol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Duration of nivolumab for pretreated, advanced non-small-cell lung cancer.
Margaux Geier, Renaud Descourt, Romain Corre, Guillaume Léveiller, Régine Lamy, Elisabeth Gaye

Cancer Med· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HER-Family Ligands Promote Acquired Resistance to Trastuzumab in Gastric Cancer.
Aïda Sampera, Francisco Javier Sánchez-Martín, Oriol Arpí, Laura Visa, Mar Iglesias, Élisabeth Gaye

Mol Cancer Ther· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intra-cranial efficacy of brigatinib in an ALK-positive non-small cell lung cancer patient presenting leptomeningeal carcinomatosis.
Elisabeth Gaye, Margaux Geier, Paul Bore, Marine Guilloïque, Francois Lucia

Lung Cancer· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis